Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Skinvisible (SKVI) EV to CFO (2010 - 2026)

Skinvisible's (SKVI) quarterly EV to CFO came in at 523.3 in Q2 2026, up 429.6% year-over-year from 98.81 in Q2 2025, and up 133.21% quarter-over-quarter from 1575.58 in Q1 2026.

Analysis

Skinvisible (SKVI) EV to CFO (2010 - 2026) Analysis & Trends

Skinvisible has disclosed EV to CFO across 17 years of filings, most recently posting 523.3 for Q2 2026.

  • In Q2 2026, EV to CFO rose 429.6% year-over-year to 523.3; the TTM figure through Jun 2026 stood at 294.65 (up 1521.06% YoY), while the FY2025 annual figure was 32.29, down 25.46% from the prior year.
  • EV to CFO came in at 523.3 for Q2 2026 at Skinvisible, up from 1575.58 in the prior quarter.
  • In the past five years, EV to CFO ranged from a high of 1545.67 in Q3 2025 to a low of 1575.58 in Q1 2026.
  • Average EV to CFO over 5 years is 7.55, with a median of 26.02 recorded in 2023.
  • Year-over-year, EV to CFO jumped 760.89% in 2025 and tumbled 1501.41% in 2026.
  • Over 5 years, EV to CFO stood at 8.19 in 2022, then tumbled by 1051.47% to 94.28 in 2023, then dropped by 12.73% to 106.28 in 2024, then jumped by 690.88% to 627.98 in 2025, then slipped by 16.67% to 523.3 in 2026.
  • Per Business Quant data, the three most recent EV to CFO figures were 523.3 in Q2 2026, 1575.58 in Q1 2026, and 627.98 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.78 Bn 626.02 Bn 17.26 Bn
2 AbbVie 439.42 Bn 432.85 Bn 12.70 Bn
3 Merck 364.63 Bn 357.49 Bn 12.21 Bn
4 Novartis Ag 268.84 Bn 261.15 Bn 11.24 Bn
5 Pfizer 158.75 Bn 147.05 Bn 10.94 Bn
6 Sanofi 52.62 Bn 45.24 Bn 10.79 Bn
7 Revolution Medicines 44.27 Bn 44.27 Bn -
8 Incyte 24.99 Bn 20.45 Bn 1.57 Bn
9 United Therapeutics 21.13 Bn 18.47 Bn 683.80 Mn
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 523.30
Mar 31, 2026 -1,575.58
Dec 31, 2025 627.98
Sep 30, 2025 1,545.67
Jun 30, 2025 -158.77
Mar 31, 2025 -98.39
Dec 31, 2024 -106.28
Sep 30, 2024 -233.88
Jun 30, 2024 -130.31
Mar 31, 2024 -25.20
Dec 31, 2023 -94.28
Sep 30, 2023 -65.81
Jun 30, 2023 -26.84
Mar 31, 2023 -6.46
Dec 31, 2022 -8.19
Sep 30, 2022 -19.57
Jun 30, 2022 2.34
Mar 31, 2022 -13.80
Dec 31, 2021 6.65
Sep 30, 2021 6.81